Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 16, 2017
Pernix Therapeutics Reports First Quarter 2017 Financial Results and Provides Business Update
MORRISTOWN, N.J., May 15, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced financial results ...
May 16, 2017
Windtree Therapeutics Reports First Quarter 2017 Financial Results and Provides Key Business Updates
WARRINGTON, Pa., May 15, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported ...
May 16, 2017
Threshold Pharmaceuticals Reports First Quarter Financial Results
MENLO PARK, Calif., May 15, 2017 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (THLD) today reported financial results for the first quarter ended March 31, 2017, ...
May 16, 2017
Santhera to Present Data and Host Symposium on Pulmonary Function in Duchenne Muscular Dystrophy at the American Thoracic Society 113th Annual Conference
Liestal, Switzerland, May 16, 2017 - Santhera Pharmaceuticals, a specialty pharmaceutical company focused on the development of innovative treatments for rare mitochondrial and neuromuscular diseases, announces ...
May 16, 2017
BrainStorm Initiated Technology Transfer to City of Hope for U.S. Production of NurOwn® for Phase 3 ALS Study
HACKENSACK, N.J., PETACH TIKVA, Israel and DUARTE, Calif., May 16, 2017 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies ...
May 16, 2017
Kamada Reports 2017 First Quarter Financial Results
NESS ZIONA, Israel, May 16, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd.  (KMDA) (KMDA.TA), a plasma-derived protein therapeutics company focused on orphan indications, today announced financial ...
May 16, 2017
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on May 16, 2017
CRANBURY, N.J., May 16, 2017 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases ...
May 16, 2017
Altimmune Promotes Dr. Sybil Tasker to Chief Medical Officer
GAITHERSBURG, Md., May 16, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced the promotion of Sybil Tasker, M.D., FACP, FIDSA, ...
May 16, 2017
Albireo Announces Two New U.S. Patents Allowed for A4250 with Term into 2031
BOSTON, May 16, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
May 16, 2017
CTD Holdings to Host Webinar to Provide Update on Trappsol(R) Cyclo(TM) Drug Development Program for Treatment of Niemann-Pick Disease Type C
ALACHUA, FL--(Marketwired - May 16, 2017) - CTD Holdings, Inc. (CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, ...
May 15, 2017
INNATE PHARMA : First quarter 2017 report
Marseille, France, May 15, 2017, 7:00 AM CEST -- Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announced its revenues and cash ...
May 15, 2017
Ignyta Granted Breakthrough Therapy Designation for Entrectinib by U.S. Food and Drug Administration
SAN DIEGO--(BUSINESS WIRE)-- Ignyta, Inc. (RXDX), a biotechnology company focused on precision medicine in oncology, today announced that the U.S. Food and Drug Administration (FDA) has ...
May 15, 2017
Aradigm Announces First Quarter 2017 Financial Results
Aradigm Corporation (ARDM) (the “Company”) today announced financial results for the first quarter and three months ended March 31, 2017. ...
May 15, 2017
BrainStorm Announces First Quarter 2017 Financial Results and Provides Corporate Update
HACKENSACK, N.J. and PETACH TIKVAH, Israel, May 15, 2017 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative ...
May 15, 2017
VBL Therapeutics Announces First Quarter 2017 Financial Results
TEL AVIV, Israel, May 15, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
May 15, 2017
Aurinia Reports First Quarter 2017 Financial Results, Announces Initiation of Phase III Aurora Clinical Trial, and Provides Operational Highlights
VICTORIA, British Columbia--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (AUPH) (AUP.TO) (“Aurinia” or the “Company”) has released its financial results for the first quarter ended March 31, 2017. ...
May 15, 2017
Eiger BioPharmaceuticals Completes Enrollment of Phase 2 LIBERTY Study of Ubenimex in Pulmonary Arterial Hypertension
PALO ALTO, Calif., May 15, 2017 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced ...
May 15, 2017
Alcobra Announces Leadership Update
TEL AVIV, Israel, May 15, 2017 (GLOBE NEWSWIRE) -- Alcobra Ltd. (ADHD), an emerging pharmaceutical company focused on the development of new medications to treat ...
May 15, 2017
Minerva Announces Outcome of End-of-Phase 2 Meeting With FDA
WALTHAM, Mass., May 15, 2017 (GLOBE NEWSWIRE) -- Following a recent "end-of-Phase 2" meeting with the U.S. Food and Drug Administration (FDA), Minerva Neurosciences, Inc. ...
May 15, 2017
Minerva Provides Update on Phase 3 Design and Development Strategy for MIN-101
WALTHAM, Mass., May 15, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
Page 140 of 145